Dominguez Gutierrez PR, Kwenda EP, Donelan W, OMalley P, Crispen PL, Kusmartsev S
2.2 Key Patent Expiry Dates and Early Launches For GLP-1 drugs, patent timing has played a critical role: Indian government and ICMR documents note that, as a concrete milestone, the core patent for semaglutide expired on March 20, 2026, triggering immediate generic launches and a sharp price drop across India.[4] According to Business Standard, more than 40 Indian drugmakers including Sun Pharma, Dr
1 Askarpour M, Hadi A, Miraghajani M, Symonds ME, Sheikhi A, Ghaedi E. Beneficial effects of L-carnitine supplementation for weight control in overweight and obese adults: an updated systematic review and dose-response meta-analysis of randomized controlled trials. Pharmacol Res. 2020 Jan;151:104554. doi: 10.1016/j.phrs.2019.104554. epub 2019 Nov 17. PMID: 31743774
,